Please check your internet connection and try again.
## Sodium Phosphate Enema
### Overview
Sodium phosphate enema is a hypertonic saline solution used as a bowel cleansing agent. It acts by drawing water into the colon via osmosis, which softens stool and stimulates defecation.
### Primary Indications
* Bowel preparation for diagnostic procedures (e.g., colonoscopy, sigmoidoscopy).
* Bowel preparation for surgery.
* Relief of occasional constipation.
### Adult Dosing
* **Bowel Preparation:** Typically, one 4.5 fl oz (133 mL) bottle administered once, usually the evening before or morning of the procedure, as directed by the prescribing physician or protocol. The dose may be repeated if necessary and tolerated, but caution is advised.
* **Constipation Relief:** One 2.25 fl oz (67 mL) bottle administered as a single dose.
### Pediatric Dosing
* **Children 2-11 years:** One 1.125 fl oz (33 mL) bottle administered as a single dose for constipation relief.
* **Children under 2 years:** Safety and efficacy are not established. Use with extreme caution and only under strict medical supervision, if at all. Dosing should be individualized and based on physician recommendation.
### Dose Adjustments
* No specific dose adjustments are typically required for hepatic or renal impairment, but caution is advised due to the risk of electrolyte disturbances.
### Contraindications
* Congestive heart failure.
* Renal impairment.
* Ascites.
* Gastrointestinal obstruction or perforation.
* Congenital megacolon.
* Ileus.
* Severe, uncorrected electrolyte abnormalities (e.g., hyperphosphatemia, hypocalcemia).
* Known hypersensitivity to sodium phosphate.
* Children under 2 years of age (caution advised).
* Patients on medications that affect electrolyte balance or kidney function.
### Adverse Effects
* **Common:** Abdominal cramping, bloating, nausea, vomiting, anal irritation.
* **Serious:**
* **Electrolyte Disturbances:** Hyperphosphatemia, hypocalcemia, hypernatremia, hypokalemia. Symptoms can include muscle twitching, tetany, cardiac arrhythmias, seizures, dehydration.
* **Renal Toxicity:** Acute kidney injury, particularly in patients with pre-existing renal disease or those who receive repeated doses.
* **Hypersensitivity Reactions:** Rash, urticaria, anaphylaxis.
### Key Drug Interactions
* **Diuretics (thiazide and loop):** Increased risk of electrolyte imbalance.
* **ACE inhibitors and ARBs:** Increased risk of hyperkalemia and renal dysfunction.
* **NSAIDs:** Increased risk of renal dysfunction and electrolyte imbalance.
* **Other laxatives:** May potentiate fluid and electrolyte loss.
### Monitoring
* Monitor for signs and symptoms of dehydration and electrolyte imbalance (e.g., thirst, dry mouth, decreased urine output, dizziness, muscle cramps, confusion, cardiac palpitations).
* Consider baseline and post-administration serum electrolytes (phosphate, calcium, sodium, potassium) in patients with risk factors for electrolyte disturbance or renal impairment.
* Monitor renal function in patients with pre-existing renal disease or those receiving repeated doses.
### Clinical Pearls
* Ensure adequate hydration before and after administration.
* Do not use for prolonged or chronic constipation.
* Do not administer to patients with any contraindications.
* Caution in elderly patients and those with cardiac, renal, or hepatic disease.
* Patient education on proper administration technique is crucial.
* The risk of serious adverse events, including renal failure and severe electrolyte abnormalities, has led to warnings and recommendations for more conservative use, especially in certain patient populations.
***
_Please verify current prescribing information and consult with a healthcare professional for specific patient management._
